These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 25012722)
1. MicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4. Ning FL; Wang F; Li ML; Yu ZS; Hao YZ; Chen SS Diagn Pathol; 2014 Jul; 9():143. PubMed ID: 25012722 [TBL] [Abstract][Full Text] [Related]
2. MiR-21 modulates chemosensitivity of tongue squamous cell carcinoma cells to cisplatin by targeting PDCD4. Ren W; Wang X; Gao L; Li S; Yan X; Zhang J; Huang C; Zhang Y; Zhi K Mol Cell Biochem; 2014 May; 390(1-2):253-62. PubMed ID: 24609942 [TBL] [Abstract][Full Text] [Related]
3. miR-107 regulates cisplatin chemosensitivity of A549 non small cell lung cancer cell line by targeting cyclin dependent kinase 8. Zhang Z; Zhang L; Yin ZY; Fan XL; Hu B; Wang LQ; Zhang D Int J Clin Exp Pathol; 2014; 7(10):7236-41. PubMed ID: 25400821 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of miR-141 reverses cisplatin resistance in non-small cell lung cancer cells via upregulation of programmed cell death protein 4. Fu WF; Chen WB; Dai L; Yang GP; Jiang ZY; Pan L; Zhao J; Chen G Eur Rev Med Pharmacol Sci; 2016 Jun; 20(12):2565-72. PubMed ID: 27383306 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of microRNA-21 expression restrains non-small cell lung cancer cell proliferation and migration through upregulation of programmed cell death 4. Yang Y; Meng H; Peng Q; Yang X; Gan R; Zhao L; Chen Z; Lu J; Meng QH Cancer Gene Ther; 2015 Jan; 22(1):23-9. PubMed ID: 25477028 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-185-5p modulates chemosensitivity of human non-small cell lung cancer to cisplatin via targeting ABCC1. Pei K; Zhu JJ; Wang CE; Xie QL; Guo JY Eur Rev Med Pharmacol Sci; 2016 Nov; 20(22):4697-4704. PubMed ID: 27906433 [TBL] [Abstract][Full Text] [Related]
8. Role of microRNA-21 in radiosensitivity in non-small cell lung cancer cells by targeting PDCD4 gene. Jiang LP; He CY; Zhu ZT Oncotarget; 2017 Apr; 8(14):23675-23689. PubMed ID: 28423589 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line. Li JH; Luo N; Zhong MZ; Xiao ZQ; Wang JX; Yao XY; Peng Y; Cao J Tumour Biol; 2016 Feb; 37(2):2387-94. PubMed ID: 26376998 [TBL] [Abstract][Full Text] [Related]
10. miR-202 Enhances the Anti-Tumor Effect of Cisplatin on Non-Small Cell Lung Cancer by Targeting the Ras/MAPK Pathway. Sun W; Ping W; Tian Y; Zou W; Liu J; Zu Y Cell Physiol Biochem; 2018; 51(5):2160-2171. PubMed ID: 30522099 [TBL] [Abstract][Full Text] [Related]
11. miR-148b reverses cisplatin-resistance in non-small cell cancer cells via negatively regulating DNA (cytosine-5)-methyltransferase 1(DNMT1) expression. Sui C; Meng F; Li Y; Jiang Y J Transl Med; 2015 Apr; 13():132. PubMed ID: 25927928 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-218 regulates cisplatin (DPP) chemosensitivity in non-small cell lung cancer by targeting RUNX2. Xie J; Yu F; Li D; Zhu X; Zhang X; Lv Z Tumour Biol; 2016 Jan; 37(1):1197-204. PubMed ID: 26282001 [TBL] [Abstract][Full Text] [Related]
14. MiR-124 changes the sensitivity of lung cancer cells to cisplatin through targeting STAT3. Qi MM; Ge F; Chen XJ; Tang C; Ma J Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5242-5250. PubMed ID: 31298375 [TBL] [Abstract][Full Text] [Related]
15. MiR-155 inhibits proliferation and invasion by directly targeting PDCD4 in non-small cell lung cancer. Liu F; Song D; Wu Y; Liu X; Zhu J; Tang Y Thorac Cancer; 2017 Nov; 8(6):613-619. PubMed ID: 28842954 [TBL] [Abstract][Full Text] [Related]
16. MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer. Li B; Ren S; Li X; Wang Y; Garfield D; Zhou S; Chen X; Su C; Chen M; Kuang P; Gao G; He Y; Fan L; Fei K; Zhou C; Schmit-Bindert G Lung Cancer; 2014 Feb; 83(2):146-53. PubMed ID: 24331411 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of PEBP4, a target of miR-34a, sensitizes drug-resistant lung cancer cells. Yu G; Zhong N; Chen G; Huang B; Wu S Tumour Biol; 2014 Oct; 35(10):10341-9. PubMed ID: 25038915 [TBL] [Abstract][Full Text] [Related]
18. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis. Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-1 overexpression increases chemosensitivity of non-small cell lung cancer cells by inhibiting autophagy related 3-mediated autophagy. Hua L; Zhu G; Wei J Cell Biol Int; 2018 Sep; 42(9):1240-1249. PubMed ID: 29851226 [TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L. Yang GD; Huang TJ; Peng LX; Yang CF; Liu RY; Huang HB; Chu QQ; Yang HJ; Huang JL; Zhu ZY; Qian CN; Huang BJ PLoS One; 2013; 8(10):e78355. PubMed ID: 24194922 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]